Your browser doesn't support javascript.
loading
Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.
Geraldo, Luiz Henrique Medeiros; Spohr, Tânia Cristina Leite de Sampaio; Amaral, Rackele Ferreira do; Fonseca, Anna Carolina Carvalho da; Garcia, Celina; Mendes, Fabio de Almeida; Freitas, Catarina; dosSantos, Marcos Fabio; Lima, Flavia Regina Souza.
Affiliation
  • Geraldo LHM; Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Spohr TCLS; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Amaral RFD; Instituto Estadual do Cérebro Paulo Niemeyer-Secretaria de Estado de Saúde, Rio de Janeiro, Brazil.
  • Fonseca ACCD; Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Garcia C; Instituto de Saúde de Nova Friburgo, Universidade Federal Fluminense, 28625-650, Nova Friburgo, Brazil.
  • Mendes FA; Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Freitas C; Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • dosSantos MF; Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Lima FRS; Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Signal Transduct Target Ther ; 6(1): 45, 2021 02 01.
Article in En | MEDLINE | ID: mdl-33526777
ABSTRACT
Lysophosphatidic acid (LPA) is an abundant bioactive phospholipid, with multiple functions both in development and in pathological conditions. Here, we review the literature about the differential signaling of LPA through its specific receptors, which makes this lipid a versatile signaling molecule. This differential signaling is important for understanding how this molecule can have such diverse effects during central nervous system development and angiogenesis; and also, how it can act as a powerful mediator of pathological conditions, such as neuropathic pain, neurodegenerative diseases, and cancer progression. Ultimately, we review the preclinical and clinical uses of Autotaxin, LPA, and its receptors as therapeutic targets, approaching the most recent data of promising molecules modulating both LPA production and signaling. This review aims to summarize the most update knowledge about the mechanisms of LPA production and signaling in order to understand its biological functions in the central nervous system both in health and disease.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phospholipids / Lysophospholipids / Neovascularization, Pathologic Limits: Humans Language: En Journal: Signal Transduct Target Ther Year: 2021 Document type: Article Affiliation country: Brazil

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phospholipids / Lysophospholipids / Neovascularization, Pathologic Limits: Humans Language: En Journal: Signal Transduct Target Ther Year: 2021 Document type: Article Affiliation country: Brazil
...